<?xml version="1.0" encoding="UTF-8"?>
<p>Results of preclinical and clinical trials, experimental studies reveal that dsRNAs exhibit inhibitory action against a wide range of viruses, as well as the adjuvant properties demonstrated in relation to vaccines against various viral infections. Modern trends of pharmaceutical development include improvement of dosage forms of dsRNA, the development of targeted delivery tools to improve antiviral efficacy and improve the therapeutic properties of such drugs.</p>
